These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 15818162)

  • 21. Durable complete remission induced by cetuximab monotherapy in a patient infected with HIV and diagnosed with recurrent squamous cell carcinoma of the head and neck.
    Rubinstein PG; Lindgren V; Setty S; Yao M; Pytynia KB; Radosevich JA; Kadkol SS; Feldman LE
    J Clin Oncol; 2011 Mar; 29(9):e222-5. PubMed ID: 21189379
    [No Abstract]   [Full Text] [Related]  

  • 22. Head and neck oncology--2010, part II.
    Myers EN
    Otolaryngol Pol; 2010; 64(4):204-14. PubMed ID: 20873095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antitumor effects of IDN5109 on head and neck squamous cell carcinoma.
    Sano D; Matsuda H; Ishiguro Y; Nishimura G; Kawakami M; Tsukuda M
    Oncol Rep; 2006 Feb; 15(2):329-34. PubMed ID: 16391850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Randomized Phase II Study of Cabazitaxel Versus Methotrexate in Patients With Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Previously Treated With Platinum-Based Therapy.
    Machiels JP; Van Maanen A; Vandenbulcke JM; Filleul B; Seront E; Henry S; D'Hondt L; Lonchay C; Holbrechts S; Boegner P; Brohee D; Dequanter D; Louviaux I; Sautois B; Whenham N; Berchem G; Vanderschueren B; Fontaine C; Schmitz S; Gillain A; Schoonjans J; Rottey S
    Oncologist; 2016 Dec; 21(12):1416-e17. PubMed ID: 27903924
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Moving towards personalised therapy in head and neck squamous cell carcinoma through analysis of next generation sequencing data.
    Giefing M; Wierzbicka M; Szyfter K; Brenner JC; Braakhuis BJ; Brakenhoff RH; Bradford CR; Sorensen JA; Rinaldo A; Rodrigo JP; Takes RP; Ferlito A
    Eur J Cancer; 2016 Mar; 55():147-57. PubMed ID: 26851381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of current treatment practices for carcinoma of the head and neck.
    Modi BJ; Knab B; Feldman LE; Mundt AJ; Yao M; Pytynia KB; Epstein J
    Expert Opin Pharmacother; 2005 Jun; 6(7):1143-55. PubMed ID: 15957968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
    Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
    Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Head and neck oncology--2010, Part I.
    Myers EN
    Otolaryngol Pol; 2010; 64(3):136-46. PubMed ID: 20731202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical Management of Head and Neck Cancer Cases: Role of Pharmacogenetics of CYP2 and GSTs.
    Ruwali M; Dhawan A; Pant MC; Rahman Q; Khurana SM; Parmar D
    Oncol Res Treat; 2016; 39(4):221-6. PubMed ID: 27160276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Docetaxel associated pathways in cisplatin resistant head and neck squamous cell carcinoma: a pilot study.
    Yoo GH; Lin HS; Iskander AJ; Piechocki MP; Oliver J; Kewson D; Lonardo F; Tainsky MA; Kim HR; Kim H; Ensley JF
    Laryngoscope; 2005 Nov; 115(11):1938-46. PubMed ID: 16319602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Research progress of squamous cell carcinoma of head and neck EGFR targeted therapy resistance mechanisms].
    Song Q; Li X
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Jan; 29(2):184-90. PubMed ID: 25989677
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emphasizing on heat shock protein 90's utility in head and neck squamous cell carcinoma treatment.
    Routray S; Sunkavalli A; Swain N; Shankar AA
    J Cancer Res Ther; 2013; 9(4):583-6. PubMed ID: 24518700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidermal growth factor receptor targeting in head and neck cancer: have we been just skimming the surface?
    Hansen AR; Siu LL
    J Clin Oncol; 2013 Apr; 31(11):1381-3. PubMed ID: 23460713
    [No Abstract]   [Full Text] [Related]  

  • 35. Neoadjuvant modified TPF (docetaxel, cisplatin, fluorouracil) for patients unfit to standard TPF in locally advanced head and neck squamous cell carcinoma: a study of 48 patients.
    Fayette J; Fontaine-Delaruelle C; Ambrun A; Daveau C; Poupart M; Ramade A; Zrounba P; Neidhardt EM; Péron J; Diallo A; Céruse P
    Oncotarget; 2016 Jun; 7(24):37297-37304. PubMed ID: 27119503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase II trial of the BCL-2 homolog domain 3 mimetic AT-101 in combination with docetaxel for recurrent, locally advanced, or metastatic head and neck cancer.
    Swiecicki PL; Bellile E; Sacco AG; Pearson AT; Taylor JM; Jackson TL; Chepeha DB; Spector ME; Shuman A; Malloy K; Moyer J; McKean E; McLean S; Sukari A; Wolf GT; Eisbruch A; Prince M; Bradford C; Carey TE; Wang S; Nör JE; Worden FP
    Invest New Drugs; 2016 Aug; 34(4):481-9. PubMed ID: 27225873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck.
    Cho BC; Keum KC; Shin SJ; Choi HJ; Lee YJ; Kim SH; Choi EC; Kim JH
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):27-32. PubMed ID: 19381630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Radio-chemotherapy in head and neck cancer (EGFR+)].
    Ozsahin M; Matzinger O; Zimmermann M; Zouhair A
    Bull Cancer; 2007 Sep; 94(9):828-32. PubMed ID: 17878104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MED15: a potential biomarker for head and neck squamous cell carcinoma?
    Offermann A; Adler D; Perner S
    Biomark Med; 2015; 9(10):939-41. PubMed ID: 26457685
    [No Abstract]   [Full Text] [Related]  

  • 40. Single-agent docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN).
    Zenda S; Onozawa Y; Boku N; Iida Y; Ebihara M; Onitsuka T
    Jpn J Clin Oncol; 2007 Jul; 37(7):477-81. PubMed ID: 17720737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.